Stock listing

Inmune Bio Inc.

Selected listing: INMB · NASDAQ · USD · US

Inmune Bio Inc. (NASDAQ:INMB), Health Technology. Latest release Oct 6, 2026: INmune Bio to Attend the 2026 Maxim Growth Summit.

INMB:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:INMB
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Inmune Bio Inc.

Inmune Bio Inc. is a public company traded under the ticker INMB in the American market. Inmune Bio focuses on developing innovative therapies to treat diseases by harnessing the body's immune system.

Latest news from Inmune Bio Inc.

INmune Bio to Attend the 2026 Maxim Growth Summit

October 6, 2026

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

September 14, 2026

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

September 9, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

August 26, 2026

INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

August 6, 2026

All Inmune Bio Inc. news →

Events

Replays

INmune Bio Inc. (INMB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
INmune Bio Inc. (INMB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
INmune Bio Inc. (INMB) Q4 2025 Earnings Call
Mon, Mar 30, 2026 · 04:30 PM ET
Watch